Manulife (Manufacturers Life Insurance)
CYCN icon

Manulife (Manufacturers Life Insurance)’s Cyclerion Therapeutics CYCN Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-709
Closed -$86K – 2999
2020
Q3 		$86K Hold
709
– – ﹤0.01% 2826
2020
Q2 		$84K Buy
709
+15
+2% +$1.25K ﹤0.01% 2797
2020
Q1 		$37K Buy
+694
New +$49.5K ﹤0.01% 2760
2019
Q4 		– Sell
-816
Closed -$216K – 2877
2019
Q3 		$216K Buy
816
+31
+4% +$6.7K ﹤0.01% 2536
2019
Q2 		$180K Buy
+785
New +$222K ﹤0.01% 2701

Other funds holding CYCN

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s CYCN Position: Q4 2020 in Review

Manulife (Manufacturers Life Insurance) sold out of Cyclerion Therapeutics (CYCN) in Q4 2020, closing a stake of 709 shares — an estimated $86K sold.

Manulife (Manufacturers Life Insurance) first reported a position in CYCN in Q2 2019 and held it in 5 quarters. The position peaked at $216K in Q3 2019. 73 funds tracked by Wall St. Rank hold CYCN as of Q4 2020.

  • Manulife (Manufacturers Life Insurance) reported no remaining Cyclerion Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 709 Cyclerion Therapeutics shares in Q4 2020, an estimated $86K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Cyclerion Therapeutics in Q2 2019 and held it in 5 quarters.
  • Manulife (Manufacturers Life Insurance)'s Cyclerion Therapeutics position peaked at $216K in Q3 2019.
  • 73 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q4 2020.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2020, filed 12 Feb 2021.